Manicaland PrEP Uptake Through Interactive Counselling Trial

NCT ID: NCT03565575

Last Updated: 2023-09-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1055 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-07

Study Completion Date

2021-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Primary Objective:

The purpose of this trial is to evaluate the impact of an interactive tablet based counselling session correcting risk perception and addressing ambiguity around availability, usability and effectiveness of PrEP on PrEP uptake within 6 months in adolescent girls and young women (AGYW) aged 18-24 years.

Hypothesis:

Correcting misperceptions of risks of HIV infection and off-setting ambiguity effects about the availability, usability and efficacy of PrEP, through localized, interactive, tablet-based counselling, will increase uptake of PrEP in HIV-negative AGYW.

Study outcomes:

The primary outcomes for the study will be risk perception measured in a follow-up survey at 6 months and proportion of women taking up PrEP within 6 months measured with biomarkers of plasma antiretroviral (ARV) drug presence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

With 6 clusters per arm, mean cluster size of 48 individuals, with co-efficient of variation in outcomes between 0.15 to 0.55, the trial will have 80% power to detect difference of 5 - 9 percentage points when baseline PrEP uptake is assumed to be 1%.

Primary analysis:

A two-stage intention-to-treat (ITT) analysis of cluster level summaries will be used. The parameter of interest is the adjusted risk difference in primary and secondary outcomes.

In the first stage, Logistic regression will be used to adjust for confounding variables at the individual level. The model will be fitted using data from both trial arms. The regression model will include terms for the covariates of interest and pair but not trial arm. Adjustment variables will include age group (\<20, 20-24), highest level of education completed, marital status and baseline measures of outcomes. In the second stage, a formal statistical comparison for differences in observed versus expected uptake by arm will be conducted using a two-sided paired significance test with α=0.05.

Secondary analysis:

In secondary analysis, the complier average causal effect (CACE) will be estimated using an instrumental variables approach. The parameter of interest is the adjusted risk difference in primary and secondary outcomes.

Heterogeneity by age and baseline levels of risk and time preferences will also be estimated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Improving Perceptions of HIV Risk Improving Uptake of Pre-exposure Prophylaxis for HIV

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

matched-cluster randomized controlled trial
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interactive tablet-based quiz

Individuals participate in an interactive tablet-based risk perception and PrEP counselling information session.

Group Type EXPERIMENTAL

Interactive tablet-based quiz

Intervention Type BEHAVIORAL

Intervention participants play an interactive tablet based quiz including the following information components:

1. Risks of HIV infection under different scenarios such as between two hypothetical individuals and with different behaviours.
2. Interactive counselling on key facts around PrEP, its usability and local availability

All individuals will have the option to sign up for contact by a nurse from the health clinic to discuss PrEP further and make an appointment for a visit. Participants will also be given a PrEP referral letter which they can present directly at one of the participating study clinics to begin PrEP. In two sites a community-led intervention will also be implemented to address social obstacles and to increase support from peers, families and social structures.

Control arm

No intervention will be administered to the control arm

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interactive tablet-based quiz

Intervention participants play an interactive tablet based quiz including the following information components:

1. Risks of HIV infection under different scenarios such as between two hypothetical individuals and with different behaviours.
2. Interactive counselling on key facts around PrEP, its usability and local availability

All individuals will have the option to sign up for contact by a nurse from the health clinic to discuss PrEP further and make an appointment for a visit. Participants will also be given a PrEP referral letter which they can present directly at one of the participating study clinics to begin PrEP. In two sites a community-led intervention will also be implemented to address social obstacles and to increase support from peers, families and social structures.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women
* Age 18-24 years

Exclusion Criteria

* Participants testing HIV-positive at baseline
* Self-reporting taking PrEP at baseline
Minimum Eligible Age

18 Years

Maximum Eligible Age

24 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Biomedical Research and Training Institute, Zimbabwe

OTHER

Sponsor Role collaborator

University of Copenhagen

OTHER

Sponsor Role collaborator

London School of Economics and Political Science

OTHER

Sponsor Role collaborator

National Institute of Mental Health (NIMH)

NIH

Sponsor Role collaborator

Simon Gregson

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Simon Gregson

Professor of Demography and Behavioural Science

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Simon Gregson, PhD

Role: PRINCIPAL_INVESTIGATOR

Imperial College London

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Manicaland Centre for Public Health Research

Bonda, Manicaland Province, Zimbabwe

Site Status

Manicaland Centre for Public Health Research

Eastern Highlands, Manicaland Province, Zimbabwe

Site Status

Manicaland Centre for Public Health Research

Hobhouse, Manicaland Province, Zimbabwe

Site Status

Manicaland Centre for Public Health Research

Honde, Manicaland Province, Zimbabwe

Site Status

Manicaland Centre for Public Health Research

Nyazura, Manicaland Province, Zimbabwe

Site Status

Manicaland Centre for Public Health Research

Sakubva, Manicaland Province, Zimbabwe

Site Status

Manicaland Centre for Public Health Research

Selbourne, Manicaland Province, Zimbabwe

Site Status

Manicaland Centre for Public Health Research

Nyanga, , Zimbabwe

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Zimbabwe

References

Explore related publications, articles, or registry entries linked to this study.

Thomas R, Skovdal M, Galizzi MM, Schaefer R, Moorhouse L, Nyamukapa C, Maswera R, Mandizvidza P, Hallett TB, Gregson S. Improving risk perception and uptake of pre-exposure prophylaxis (PrEP) through interactive feedback-based counselling with and without community engagement in young women in Manicaland, East Zimbabwe: study protocol for a pilot randomized trial. Trials. 2019 Dec 2;20(1):668. doi: 10.1186/s13063-019-3791-8.

Reference Type DERIVED
PMID: 31791405 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01MH114562-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

P67251_PrEP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Project Engage: Oral PrEP Acceptability
NCT05458765 COMPLETED PHASE2
The Test-to-PrEP Study
NCT06927856 RECRUITING NA
Life Steps for PrEP for Youth
NCT03805451 COMPLETED NA
Pre-Exposure Prophylaxis in YMSM
NCT01033942 COMPLETED PHASE2